CN Stock MarketDetailed Quotes

301520 Anhui Wanbang Pharmaceutical Technology

Watchlist
  • 41.95
  • -1.28-2.96%
Market Closed Nov 15 15:00 CST
2.80BMarket Cap25.75P/E (TTM)

About Anhui Wanbang Pharmaceutical Technology Company

The company was founded in 2006, the first CRO share in Anhui Province, and is one of the earliest CRO companies in China to provide drug research and development services. The company's main business is pharmaceutical research and clinical research services. The company's main products and services include clinical trial operation (CO), clinical trial site management (SMO), biological sample analysis (BA), data management and statistical analysis (DM/ST), etc. Since its establishment, the company has won many honors such as Hefei Intellectual Property Demonstration Enterprise, Service Industry Regulatory Enterprise, Top 20 Chinese Pharmaceutical Outsourcing Companies, Communist Youth League Hefei Youth Civilization Award, All-China Federation of Industry and Commerce Star Council Member Unit, and the 2018 “Outstanding Contribution Award - High Growth and Quality Award”.

Company Profile

Short Name-A万邦医药
Symbol-A301520
Company NameAnhui Wanbang Pharmaceutical Technology Co.,Ltd.
Listing DateSep 25, 2023
Issue Price67.88
Shares Offered16.67M share(s)
FoundedMar 1, 2006
Legal Representativechunlei tao
General Managerchunlei tao
Secretarymei liu
Accounting FirmRong Cheng Certified Public Accountants (Special General Partnership)
Securities Representativeting yang
Legal CounselAnhui Chengyi Law Firm
Employees479
Phone0551-65397676
Office AddressNo. 299, Huolongdi Road, High-tech Zone, Hefei, Anhui
Zip Code230031
Registered AddressNo. 299, Huolongdi Road, High-tech Zone, Hefei, Anhui
Fax0551-65397675
Emailwbyydmb@ahwbyy.cn
Business License340106000026329
BusinessR&D, development and transfer, testing and analytical testing of pharmaceutical products, diagnostic reagents, medical devices, health foods, health products, and cosmetic technology; pharmaceutical sales (operated with a license), intermediary services (excluding special licensing projects). (For projects requiring approval according to law, business activities can only be carried out after approval by relevant departments)

Company Executives

  • Name
  • Position
  • Salary
  • chunlei tao
  • Chairman, Directors, General Manager, Member of the Remuneration and Assessment Committee, Chairman of the Strategy Committee, Nomination Committee Members
  • 1.12M
  • yan zhou
  • Directors, Deputy General Manager
  • 830.50K
  • ying shen
  • Directors, Strategy Committee Member, Audit Committee Member
  • --
  • xinluo xu
  • Directors
  • --
  • baohong jiang
  • Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Nomination Committee, Audit Committee Member, Strategy Committee Member
  • 72.00K
  • zongcheng yin
  • Independent Directors, Chairman of the Remuneration and Assessment Committee, Chairman of the Audit Committee, Nomination Committee Members
  • 72.00K
  • mei liu
  • Board Secretary, Chief Financial Officer
  • 581.50K
  • ting yang
  • Securities Affairs Representative
  • --
  • xiaodong wang
  • Chairman of the Supervisory Board, Employee Supervisors
  • 335.30K
  • jie li
  • Auditors
  • 426.90K
  • feng shao
  • Auditors
  • 633.40K
  • rongrong liu
  • Deputy General Manager
  • --
  • xin song
  • Deputy General Manager
  • 600.70K
  • yang xu
  • Deputy General Manager
  • 651.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data